ANIK
Anika Therapeutics Inc
20.40$
-2.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.6% | -5.7% | -24.2% | +26.1% | -103.3% | – | +7.8% | -1.4% | +10.1% | -3.3% | +10.1% | – | |
| – | +0.7% | -4.5% | -35.6% | +264.6% | -163.9% | – | +20.6% | -11.7% | -6.5% | -7.2% | +7.1% | – | |
| – | +5.6% | -6.5% | -16.8% | -93.0% | +1,467.0% | -34.9% | -2.2% | +8.5% | +23.1% | -0.9% | +11.8% | – | |
| – | -2.6% | +7.6% | -18.2% | +8.4% | -62.2% | +121.3% | +4.2% | +10.0% | -7.1% | +4.0% | +9.4% | – | |
| – | -18.1% | +5.9% | -8.0% | -3.5% | -74.4% | +163.9% | -5.2% | -2.9% | +1.8% | +47.1% | -38.4% | – | |
| – | +176.3% | -67.1% | -24.9% | +32.1% | -117.8% | – | -2.2% | +1.5% | -1.5% | +32.1% | -25.3% | – | |
| – | – | – | – | – | – | -115.4% | – | – | – | -949.5% | – | – | |
| – | – | -51.2% | – | – | – | – | +51.6% | +92.5% | -90.3% | +465.3% | – | – | |
| – | – | – | – | – | – | -113.5% | – | – | – | -731.0% | – | – | |
| – | – | – | +2,983.7% | +74.0% | +24.4% | -96.9% | +665.2% | +37.9% | -210.4% | – | -69.8% | – | |
| – | – | – | – | – | – | – | – | – | – | -1,831.5% | – | – | |
| – | – | -194.4% | – | -3,115.8% | – | -108.6% | – | – | – | -264.0% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.